The Gastrointestinal Oncology Program specializes in the diagnosis and multidisciplinary management of patients with pre-cancerous and cancerous conditions involving the esophagus, stomach, small intestine, colon, rectum, pancreas, retroperitoneum, and other intra-abdominal organs. Physicians offer the full spectrum of therapeutic procedures and advanced treatment options including complex surgical techniques, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), clinical trials, precision medicine, immunotherapy, treatment of advanced disease and prevention in high risk populations. Our team of gastrointestinal surgical oncologists, medical oncologists, radiation oncologists, advanced practice nurses, and oncology nurse navigators work together to make sure each aspect of care is tailored to the individual patient and their needs.
The Gastrointestinal Group meets on a weekly basis to address clinical and research issues relating to all types of GI malignancies. The team discusses treatment and patient care issues to assure that the full spectrum of cancer prevention, diagnosis, treatment and follow-up options are appropriately considered for every patient. The program integrates a spectrum of clinical, basic, and translational research activities, assuring close collaboration between basic scientists and clinicians for the rapid translation of research discoveries to clinical care and to enlist the assistance of basic researchers in solving clinical problems.
The clinical arm of the program provides interdisciplinary diagnostic and treatment options that include prevention in high risk populations, early diagnosis, therapeutic evaluations, multi-disciplinary management of patients with cancer and pre-cancerous conditions, and treatment of advanced disease. The program strives to make new prevention, diagnostic, and treatment approaches available to patients through clinical trials.
Our physicians see patients here in New Brunswick as well as at several RWJBarnabas Health facilities including Monmouth Medical Center, Jersey City Medical Center, and Cooperman Barnabas Medical Center.
Howard S. Hochster, MD. FACP, Associate Director for Clinical Research and Director, GI Oncology
H. Richard Alexander, Jr., MD, Chief Surgical Officer and Chief, Surgical Oncology, Rutgers Cancer Institute, and Regional Director of Surgery for Monmouth Medical Center, an RWJBH Facility
Daniel L. Feingold, MD, FASCRS, FACS, Chief, Colorectal Surgery
Salma Jabbour, MD, Chief, GI Radiation Oncology
Russell C. Langan, MD, Chief of Surgical Oncology & Hepatopancreatobiliary Surgery, Cooperman Barnabas Medical Center
Surgical Oncologists
H. Richard Alexander, Jr., MD, Chief Surgical Officer and Chief, Surgical Oncology, Rutgers Cancer Institute, and Regional Director of Surgery for Monmouth Medical Center, an RWJBH FacilityDaniel L. Feingold, MD, FASCRS, FACS, Chief, Colorectal Surgery
David A. August, MD, Associate Director for Faculty AffairsRussell C. Langan, MD, Chief of Surgical Oncology & Hepatopancreatobiliary Surgery, Cooperman Barnabas Medical Center
Brett L. Ecker, MD
Mariam F. Eskander, MD, MPH
Miral Sadaria Grandhi, MD, Director of Hepatobiliary Surgery
Haejin In, MD, MPH, MBA, Chief Diversity Officer, Associate Director for Diversity, Equity and Inclusion
Timothy J. Kennedy, MD, MBA
Medical Oncologists
Howard S. Hochster, MD. FACP, Associate Director for Clinical Research and Director, GI Oncology
Lyudmyla Berim, MD
Patrick Boland, MD
Prateek Gulhati, MD, PhD
Radiation Oncologists
Lara Hathout MD, FRCPC, Director of Brachytherapy, Department of Radiation OncologySalma Jabbour, MD, Chief, GI Radiation Oncology
Advanced Practice Providers
Nurses and Support Services
